Literature DB >> 7955530

Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients.

C Muscat1, A Bertotto, E Agea, O Bistoni, R Ercolani, R Tognellini, F Spinozzi, M Cesarotti, R Gerli.   

Abstract

The expression and the functional role of the CD26 (1F7) T cell surface molecule, an ectoenzyme which seems to represent a functional collagen receptor of T lymphocytes and to have a role in T cell activation, were analysed in both peripheral blood (PB) and synovial fluid (SF) T cell samples from patients with active and inactive rheumatoid arthritis (RA). Although patients with active disease displayed higher percentages of PB CD26+ CD4+ T cells than inactive RA and control subjects, CD26 antigen expression on RA SF T lymphocytes was low. The anti-1F7 binding to the T cell surface, that led to CD26 antigen modulation and enhancement of both IL-2 synthesis by, and 3H-TdR incorporation of, anti-CD3- or anti-CD2-triggered PB T cells in RA and control subjects, was unable to affect significantly both expression and functional activity of RA SF T lymphocytes. Since the 1F7 antigen spontaneously reappeared on the surface of unstimulated SF T cells after 2-5 days of culturing, the low 1F7 antigen expression of anti-1F7 in the SF T cell compartment may be the result of in vivo molecule modulation exerted by the natural ligand in the joint, with important implications for T cell activation and lymphokine synthesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7955530      PMCID: PMC1534402          DOI: 10.1111/j.1365-2249.1994.tb06134.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

Review 1.  Rheumatoid arthritis. Pathophysiology and implications for therapy.

Authors:  E D Harris
Journal:  N Engl J Med       Date:  1990-05-03       Impact factor: 91.245

2.  Direct evidence for the binding of rat liver DPP IV to collagen in vitro.

Authors:  C Hanski; T Huhle; R Gossrau; W Reutter
Journal:  Exp Cell Res       Date:  1988-09       Impact factor: 3.905

3.  1F7, a novel cell surface molecule, involved in helper function of CD4 cells.

Authors:  C Morimoto; Y Torimoto; G Levinson; C E Rudd; M Schrieber; N H Dang; N L Letvin; S F Schlossman
Journal:  J Immunol       Date:  1989-12-01       Impact factor: 5.422

4.  T cell immunoregulation in rheumatoid synovitis.

Authors:  R Gerli; A Bertotto; P Rambotti; P Barbieri; M L Ciompi; S Bombardieri
Journal:  Arthritis Rheum       Date:  1988-08

5.  Expression of activation antigens on T cells in rheumatoid arthritis patients.

Authors:  A J Potocnik; R Kinne; H Menninger; J Zacher; F Emmrich; R A Kroczek
Journal:  Scand J Immunol       Date:  1990-02       Impact factor: 3.487

6.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

7.  Mechanisms of immune memory. T cell activation and CD3 phosphorylation correlates with Ta1 (CDw26) expression.

Authors:  D A Hafler; M Chofflon; D Benjamin; N H Dang; J Breitmeyer
Journal:  J Immunol       Date:  1989-04-15       Impact factor: 5.422

8.  Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis.

Authors:  J J Cush; P E Lipsky
Journal:  Arthritis Rheum       Date:  1988-10

9.  Direct association of adenosine deaminase with a T cell activation antigen, CD26.

Authors:  J Kameoka; T Tanaka; Y Nojima; S F Schlossman; C Morimoto
Journal:  Science       Date:  1993-07-23       Impact factor: 47.728

10.  The intrinsic migratory capacity of memory T cells contributes to their accumulation in rheumatoid synovium.

Authors:  J J Cush; P Pietschmann; N Oppenheimer-Marks; P E Lipsky
Journal:  Arthritis Rheum       Date:  1992-12
View more
  22 in total

1.  CD26 T cells in the pathogenesis of asthma.

Authors:  K Ohnuma; T Yamochi; O Hosono; C Morimoto
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

2.  Streptokinase promotes development of dipeptidyl peptidase IV (CD26) autoantibodies after fibrinolytic therapy in myocardial infarction patients.

Authors:  Miguel Cuchacovich; Héctor Gatica; Paula Vial; Jorge Yovanovich; Salvatore V Pizzo; Mario Gonzalez-Gronow
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

Review 3.  Dipeptidyl Peptidase (DPP)-4 Inhibitor-Induced Arthritis/Arthralgia: A Review of Clinical Cases.

Authors:  Annamaria Mascolo; Concetta Rafaniello; Liberata Sportiello; Maurizio Sessa; Daniela Cimmaruta; Francesco Rossi; Annalisa Capuano
Journal:  Drug Saf       Date:  2016-05       Impact factor: 5.606

4.  Serum levels of soluble CD26 and CD30 and their clinical significance in patients with rheumatoid arthritis.

Authors:  Hasan Ulusoy; Ayhan Kamanli; Necip Ilhan; Omer Kuru; Sule Arslan; Gokhan Alkan; Salih Ozgocmen
Journal:  Rheumatol Int       Date:  2011-12-23       Impact factor: 2.631

5.  Circulating CD26 is negatively associated with inflammation in human and experimental arthritis.

Authors:  Nathalie Busso; Nicolai Wagtmann; Christian Herling; Veronique Chobaz-Péclat; Angelika Bischof-Delaloye; Alexander So; Eric Grouzmann
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

6.  CD26 mediates dissociation of Tollip and IRAK-1 from caveolin-1 and induces upregulation of CD86 on antigen-presenting cells.

Authors:  Kei Ohnuma; Tadanori Yamochi; Masahiko Uchiyama; Kunika Nishibashi; Satoshi Iwata; Osamu Hosono; Hiroshi Kawasaki; Hirotoshi Tanaka; Nam H Dang; Chikao Morimoto
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

Review 7.  T-cell activation via CD26 and caveolin-1 in rheumatoid synovium.

Authors:  Kei Ohnuma; Hiroshi Inoue; Masahiko Uchiyama; Tadanori Yamochi; Osamu Hosono; Nam H Dang; Chikao Morimoto
Journal:  Mod Rheumatol       Date:  2006       Impact factor: 3.023

8.  Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26.

Authors:  Mary A Fletcher; Xiao R Zeng; Kevin Maher; Silvina Levis; Barry Hurwitz; Michael Antoni; Gordon Broderick; Nancy G Klimas
Journal:  PLoS One       Date:  2010-05-25       Impact factor: 3.240

9.  Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease.

Authors:  Aristo Vojdani; Mohsen Bazargan; Elroy Vojdani; John Samadi; Alen A Nourian; Navid Eghbalieh; Edwin L Cooper
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

10.  Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients.

Authors:  Suncica Buljevic; Dijana Detel; Lara Baticic Pucar; Radovan Mihelic; Tomislav Madarevic; Branko Sestan; Jadranka Varljen
Journal:  Rheumatol Int       Date:  2013-07-18       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.